Bacterial profile, antimicrobial susceptibility patterns, and associated factors of lower respiratory tract infections among adult patients attending Nekemte Comprehensive Specialized Hospital: A cross-sectional study
This cross-sectional study conducted at Nekemte Comprehensive Specialized Hospital in Ethiopia found that 51.9% of adult patients with lower respiratory tract infections had bacterial pathogens, predominantly *Klebsiella pneumoniae* and *Pseudomonas aeruginosa*, which exhibited significant resistance to common antibiotics, while identifying age, education, marital status, and occupation as key associated factors.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breathing is the most fundamental act of life, yet the airways that carry oxygen to our blood are constantly under siege. When the lungs and the tubes leading to them become inflamed by an infection, the condition is known as a lower respiratory tract infection. These illnesses, which include pneumonia and bronchitis, are among the leading causes of sickness and death worldwide. While viruses can trigger these infections, bacteria are often the primary culprits that turn a manageable illness into a life-threatening one. The challenge for doctors is not just identifying the infection, but knowing which weapon to use against it. Antibiotics are the standard treatment, but bacteria have a troubling ability to change and resist these medicines, rendering once-effective drugs useless. When a bacterium becomes resistant, the infection lingers, the patient suffers longer, and the risk of death rises. Understanding which bacteria are causing these infections in specific places, and which antibiotics can still stop them, is essential for keeping communities healthy.
In the town of Nekemte, Ethiopia, a team of researchers set out to map this invisible battlefield. They focused on adult patients visiting the local comprehensive hospital who showed signs of a lower respiratory tract infection, such as a persistent cough, chest pain, or fever. The goal was to find out exactly which bacteria were present in their lungs and to test how well the available antibiotics could defeat them. To do this, the team collected sputum, the thick mucus coughed up from deep within the lungs, from 376 adults over a three-month period. Before testing for bacteria, they first ensured the samples were clean and free from tuberculosis, a different and serious lung disease. They then examined the samples under microscopes and grew the bacteria on special plates in a laboratory to see what would emerge. Once the bacteria were identified, the researchers placed small disks soaked in different antibiotics onto the plates to see if the drugs could stop the bacteria from growing.
The results revealed a clear picture of the bacterial landscape in Nekemte. More than half of the patients, specifically 51.9 percent, had a bacterial infection that could be grown in the lab. Among the bacteria found, the most common type was Gram-negative, a group known for having a tough outer shell that makes them harder to kill. The single most frequent bacterium identified was Klebsiella pneumoniae, which accounted for nearly one-fifth of all isolates. It was followed closely by Pseudomonas aeruginosa and Escherichia coli. While some bacteria were sensitive to the antibiotics tested, meaning the drugs worked well, many others showed resistance. For instance, the Gram-negative bacteria were highly sensitive to ciprofloxacin and a combination drug called piperacillin-tazobactam, with about 79 percent of them responding to these treatments. However, resistance was a significant problem for other common drugs; many bacteria were resistant to amoxicillin-clavulanate and tetracycline. Among the Gram-positive bacteria, which have a different cell structure, clindamycin was the most effective treatment, working against 96 percent of the samples.
The study also uncovered that the risk of catching these infections was not random; it was tied closely to a person's life circumstances. The researchers found that age, education, marital status, and occupation played a major role. Adults between the ages of 18 and 35 were significantly more likely to have an infection than older adults, as were those with no formal education. People who worked as farmers or daily laborers faced higher risks compared to students or government employees. Interestingly, being married appeared to be a protective factor, while being single or divorced was linked to a higher likelihood of infection. These patterns suggest that factors like exposure to dust, living conditions, and perhaps access to health information influence who gets sick. The researchers also noted that nearly 30 percent of the bacteria found were multidrug-resistant, meaning they could survive attacks from three or more different classes of antibiotics. This finding highlights a growing threat where standard treatments may fail.
Ultimately, the study paints a sobering but actionable portrait of lower respiratory infections in this region. It confirms that while some antibiotics remain effective, the rise of resistant bacteria is a serious concern that requires careful management. The researchers emphasize that treating these infections without first testing the bacteria is a gamble that could lead to treatment failure. By identifying the specific bacteria and knowing which drugs work, doctors can choose the right medicine immediately, sparing patients from unnecessary suffering and slowing the spread of resistance. The work underscores the need for routine testing in hospitals and the importance of understanding the social and environmental factors that put people at risk, ensuring that the tools to fight these infections remain sharp for the future.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.